Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · IEX Real-Time Price · USD
22.27
-0.52 (-2.28%)
Dec 29, 2023, 4:00 PM EST - Market closed
Company Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism.
The company develops PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias; and AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias.
Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Agios Pharmaceuticals, Inc.
| Country | United States |
| IPO Date | Jul 24, 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 389 |
| CEO | Brian M. Goff M.B.A. |
Contact Details
Address: 88 Sidney Street Cambridge, Massachusetts 02139 United States | |
| Phone | 617-649-8600 |
| Website | agios.com |
Stock Details
| Ticker Symbol | AGIO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001439222 |
| CUSIP Number | 00847X104 |
| ISIN Number | US00847X1046 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Bruce D. Car DACVP, Ph.D. | Consultant |
| Dr. Sarah Gheuens M.D., Ph.D. | Chief Medical Officer and Head of Research & Development |
| Richa Poddar | Chief Commercial Officer |
| Brian M. Goff M.B.A. | Chief Executive Officer and Director |
| Dr. Lewis Clayton Cantley Ph.D. | Co-Founder and Member of Scientific Advisory Board |
| Dr. Tak Wah Mak D.Sc., FRSC, Ph.D. | Co-Founder and Member of Scientific Advisory Board |
| Dr. Craig B. Thompson M.D. | Co-Founder and Chairman of Scientific Advisory Board |
| Dr. Shin-San Su Ph.D. | Co-Founder and Member of Scientific Advisory Board |
| Cecilia Jones | Chief Financial Officer |
| T. J. Washburn Jr. | Principal Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 9, 2023 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 9, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 2, 2023 | 10-Q | Quarterly Report |
| Nov 2, 2023 | 8-K | Current Report |
| Aug 3, 2023 | 10-Q | Quarterly Report |
| Aug 3, 2023 | 8-K | Current Report |
| Jun 14, 2023 | 8-K | Current Report |
| Jun 13, 2023 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 25, 2023 | 8-K | Current Report |
| May 4, 2023 | 10-Q | Quarterly Report |